What is Applied Membrane Technology?
Applied Membrane Technology Inc. operates at the intersection of material science and medical device innovation. The company specializes in the development of high-performance antibacterial coatings and advanced membrane solutions designed to address complex surface-related challenges. With a legacy spanning over three decades, the organization has cultivated a reputation for technical excellence, leveraging Good Manufacturing Practices (GMP) to deliver consistent, high-quality products. Their portfolio serves a diverse global clientele, ranging from established medical device manufacturers to emerging biotech entities, providing tailored solutions that facilitate rapid prototyping and commercial-scale production.
How much funding has Applied Membrane Technology raised?
Applied Membrane Technology has raised a total of $278K across 2 funding rounds:
Debt
$150K
Debt
$128K
Debt (2020): $150K with participation from PPP
Debt (2021): $128K led by PPP
Key Investors in Applied Membrane Technology
PPP
Public-Private Partnership
What's next for Applied Membrane Technology?
With the successful acquisition of this latest capital, Applied Membrane Technology is well-positioned to accelerate its research and development pipeline. The strategic focus will likely shift toward expanding its manufacturing footprint and enhancing its proprietary coating technologies to meet the evolving demands of the global biotech and industrial markets. By leveraging this late-stage investment, the company aims to solidify its competitive advantage, potentially exploring new market verticals where material surface integrity is paramount. The emphasis remains on maintaining high-quality standards while scaling operations to support the increasing complexity of modern medical device requirements.
See full Applied Membrane Technology company page
